AlphaOne Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
AlphaOne Pharmaceuticals hopes to remedy the short supply of the protein Alpha 1-antitrypsin (AAT) with a recombinant version of Bayer's plasma-derived AAT product, {Prolastin}.